The American Physiological Society Press Release

press release logo

APS Contact: APS Communications Office


Phone: 301.634.7209

Twitter: @APSPhysiology

Nobel Laureate, Esteemed Researchers Participate in APS President’s Symposium Series

Chicago (April 18, 2017)—APS President Jane Reckelhoff, PhD, of the University of Mississippi Medical Center, has developed an engaging President’s Symposium Series to be presented at the American Physiological Society (APS) annual meeting at Experimental Biology 2017 in Chicago. Three symposia will focus on the theme “Research Advances in Sex/Gender and Developmental Programming of Chronic Diseases.” Esteemed researchers in physiology will discuss sex differences in physiology and pathophysiology, women’s health research and the developmental programming of diseases. The series culminates on Wednesday with the Nobel Prize in Physiology or Medicine Lecture by Nobel Laureate Louis Ignarro, PhD, of the University of California, Los Angeles School (UCLA) of Medicine.

Sex Differences in Physiology and Pathophysiology

Sunday, April 23, at 10:30 a.m. — McCormick Place Convention Center (MPCC) Room W375A
Chair: Minolfa C. Prieto, MD, PhD, Tulane University School of Medicine


“Sex Matters in the Lung”
Y.S. Prakash, MD, PhD, Mayo Clinic

“Benefits and Risks of Testosterone Therapy in Men with Testosterone Deficiency”
Traish Abdulmaged, PhD , Boston University School of Medicine

“Reactive Oxygen Species: Players in the Effects of Testosterone”
Rita Tostes, PhD, Medical School of Ribeirao Preto, University of Sao Paulo

 “Eliciting Estrogenic Cardioprotection via GPER”
Sarah H. Lindsey, PhD, Tulane University School of Medicine

Women’s Health Research

Monday, April 24, at 10:30 a.m. — MPCC Room W375A
Chair: Heddwen Brooks, PhD, University of Arizona


“Polycystic Ovary Syndrome: Cardiovascular and Metabolic Implications”
Licy Yanes Cardoz, MD, University of Mississippi Medical Center

“Novel Mechanisms Responsible for Preeclampsia”
Joey Granger, PhD, University of Mississippi Medical Center

“A Woman Is Not a Small Man: Sex Differences in the Heart”
Leslie Anne Leinwand, PhD, University of Colorado

“An Update on Hormone Replacement Therapy in Postmenopausal Women”
Virginia Miller, PhD, Mayo Clinic

Developmental Programming of Diseases

Tuesday, April 25, at 10:30 a.m. — MPCC Room W375A
Chair: Barbara Alexander, PhD, University of Mississippi Medical Center


An Overview of the Concept of Developmental Programming”
Kent Thornburg, PhD, Oregon Health and Science University

“Actions of Bisphenol A (BPA) and Chemical Used in BPA-Free Products on the Reproductive Neuroendocrine System during Early Development”
Nancy Wayne, PhD, UCLA School of Medicine

“The Benjamin Button Approach to Understanding the Developmental Origins of Hypertension”
Kate Denton, PhD, Monash University

“Epigenetic Consequences of Adverse Fetal Life”
Torsten Plosch, PhD, University of Groningen

Nobel Prize in Physiology or Medicine Lecture

Wednesday, April 26, at 4:45 p.m. — MPCC Room W375A
“The Road to Stockholm: A Nobel Mission”
Louis Ignarro, PhD, UCLA School of Medicine

NOTE TO JOURNALISTS: To schedule an interview with a member of the research team, please contact the APS Communications Office or 301-634-7209. Find more research highlights in the APS Press Room.

About Experimental Biology 2017

Experimental Biology is an annual meeting comprised of more than 14,000 scientists and exhibitors from six sponsoring societies and multiple guest societies. With a mission to share the newest scientific concepts and research findings shaping clinical advances, the meeting offers an unparalleled opportunity for exchange among scientists from across the United States and the world who represent dozens of scientific areas, from laboratory to translational to clinical research.

Physiology is the study of how molecules, cells, tissues and organs function in health and disease. Established in 1887, the American Physiological Society (APS) was the first U.S. society in the biomedical sciences field. The Society represents more than 10,500 members and publishes 15 peer-reviewed journals with a worldwide readership.



Genes May Determine the Side Effects of Menopausal Hormone Therapy, Study Suggests

Released November 10, 2015 - Cardiovascular disease risk in women increases after menopause and is associated with the drop in estrogen levels. Menopausal hormone therapy could slow the progression, but oral formulations also increase the risk of blood clots. A new study reports that whether a woman will obtain cardiovascular benefits from certain types of hormone therapy may depend on her genes.

Menopausal Status May Better Predict Blood Vessel Health in Women than Fitness Level

Released August 12, 2017 - High physical fitness is known to be related to enhanced blood vessel dilation and blood flow (endothelial function) in aging men. However, for women, endothelial function and the effect of exercise may be related more to menopausal status than fitness. Researchers from the University of Massachusetts Amherst will present their findings today at the Cardiovascular Aging: New Frontiers and Old Friends conference in Westminster, Colo.